Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials.
Journal: The Journal of clinical psychiatry
Published: April 11, 2025
Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials.
Journal: International clinical psychopharmacology
Published: January 26, 2024
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
Journal: The Journal of clinical psychiatry
Published: August 16, 2023
Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study.
Journal: Journal of child and adolescent psychopharmacology
Published: July 12, 2023
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Journal: The American journal of psychiatry
Published: February 15, 2023
Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia.
Journal: Journal of child and adolescent psychopharmacology
Published: October 25, 2022
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.
Journal: Headache
Published: July 13, 2020
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
Journal: Cephalalgia : an international journal of headache
Published: November 23, 2019
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.
Journal: Neurology
Published: October 10, 2019
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
Journal: Headache
Published: August 27, 2019
Effect of fremanezumab on quality of life and productivity in patients with chronic migraine.
Journal: Neurology
Published: July 31, 2019
Fremanezumab for the preventive treatment of migraine.
Journal: Expert opinion on biological therapy
Published: June 11, 2019
Last Updated: 09/26/2026